Available
Inspect in 3DBatch verification pending
PendingBPC-157 + TB-500
Dual-compound format · 10 mg BPC-157 + 10 mg TB-500
From€12020 mg · 10 + 10 mg
Product developmentFormat pending
ARA-290 is listed for visibility, but no ARDEN ONE format is available yet.
Coming soonRecovery
ARA-290
Non-erythropoietic EPO-derived research peptide (cibinetide)
ARA-290 is listed in the ARDEN ONE research index. Studied in research contexts only; no ARDEN ONE format is available yet, so it cannot be ordered. For laboratory research use only. Not for human use.
Select size
For research purposes only. Not for human consumption. For laboratory and research use only by qualified personnel.
Analytical record pending
- Compound
- ARA-290
- Batch
- Pending confirmation
- Purity (HPLC)
- Pending independent analysis
- Method
- Planned, RP-HPLC / ESI-MS
- Format
- In development, no pen available
- Evidence
- Not yet issued
Record publishes after verification
- Final handling guidance will be published per production batch.
- No pen format or storage specification has been released for this product.
- Follow the signed batch record and packaging instructions supplied at launch.
- Handle under standard laboratory safety protocols only.
For research purposes only. Not for human consumption. For laboratory and research use only by qualified personnel. ARDEN ONE operates in compliance with EU regulations for research chemicals. All sales are for research use only.
Same research line